ARTICLE | Clinical News

New River starts adult ADHD Phase III

May 24, 2006 12:44 AM UTC

NRPH started a Phase III trial of NRP104 to treat adult ADHD. NRPH hopes to submit an sNDA for the indication in the second quarter of next year. The amphetamine prodrug is under review for pediatric ...